ARO8 from C. albicans exhibits 53% identity to ARO8 from S. cerevisiae, while YER152C exhibits 30% identity to ARO8 and 45% to YER152C from S. cerevisiae. We amplified two genes from the C. albicans genome: ARO8 and YER152C. Both were cloned and expressed as Histagged fusion proteins in E. coli. The purified Aro8CHp gene product revealed aromatic and α-aminoadipate aminotransferase activity. Basic molecular properties of the purified protein were determined. We obtained catalytic parameters of Aro8CHp with aromatic amino acids and aminoadipate (AA) (K m(L-Phe) 0.05±0.003 mM, K m(L-Tyr) 0.1±0.008 mM, K m(L-AA) 0.02±0.006 mM) and confirmed the enzyme broad substrate spectrum. The assays also demonstrated that this enzyme may use 2-oxoadipate and 2-oxoglutarate (2-OG) as amino acceptors. Aro8-CHp exhibited pH optima range of 8, which is similar to AmAA from S. cerevisiae. Our results also indicate that CaYer152Cp has a possible role only in aromatic amino acids degradation, in contrast to CaAro8CHp.
INTRODUCTION
l-Lysine is an essential amino acid for humans, while bacteria, plants and fungi have developed pathways of their own lysine biosynthesis. In bacteria, lower fungi (some Phycomycetes) and green plants, l-lysine is synthesized via the diaminopimelate pathway in seven steps initiating with aspartate semialdehyde and pyruvate. In Euglenoids and higher fungi (Ascomycetes and Basidomycetes), de novo l-lysine biosynthesis proceeds through the intermediacy of l-α-aminoadipate in a series of transformations entirely unrelated to the bacterial diaminopimelate route. Enzymes that catalyze the reaction of the fungal pathway could be a source of new targets for antifungal chemotherapy (Xu et al., 2006) . α-Aminoadipate pathway (AAP) of lysine biosynthesis consists of eight stages. Aminoadipate aminotransferase (AmAA) is an enzyme of AAP that catalyzes the fourth reaction: 2-oxoadipate conversion to α-aminoadipate, as shown in Fig. 1 .
Research studies confirm that enzymes exhibiting aminoadipate aminotransferase activity may be involved in several metabolic pathways, e.g. in lysine biosynthesis, Aro8p, Aro9p, Yer152Cp from S. cerevisiae and Aro8p, Aro9p, C6_00210W (Yer152Cp) from C. albicans (Matsuda & Ogur, 1969; Ghosh et al., 2008) and LysN from T. termophilus (ThtLysN) (Miyazaki et al., 2004) , as well as in tryptophan degradation (ScAro9p) and Aro8p and Aro9p from C. glabrata (Brunke et al., 2010) , and in biosynthesis of branched-chain amino acids (ScAro8p, ScAro9p and ThtLysN) (Miyazaki et al., 2004; Urrestarazu et al., 1998) , and lysine degradation (hKATII from human liver with simultaneous kynurenine aminotransferase activity) (Han et al., 2009 ). Aro8p and Aro9p from C. glabrata probably perform the same functions as ScAro8p and ScAro9p in respect to aromatic amino acid biosynthesis or degradation. Moreover, their activity is indispensable for pigment production, an important virulence factor of C. glabrata (Brunke et al., 2010) . Similarly, Aro8p and Aro9p from C. albicans are essential for aromatic alcohol production (Ghosh et al., 2008) . ScAro9p is able to catalyze the reaction in two directions, although aromatic amino acid and lysine degradation seems to be more likely .
Aro8p was initially identified as aromatic aminotransferase I, an enzyme involved in the biosynthesis of phenylalanine and tyrosine Vol. 62, No 4/2015 903-912 http://dx.doi.org/10. 18388/abp.2015_1158 et al., 1998 Bulfer et al., 2013) . Similarly to many class I aminotransferases, Aro8p exhibits a broad substrate specificity and has been reported to utilize glutamate, phenylalanine, tyrosine and tryptophan as amino donors, with phenylpyruvate, 4-hydroxyphenylpyruvate, 2-oxoglutarate and pyruvate as amino acceptors (Kradolfer et al., 1982; Iraqui et al., 1998; Urrestarazu et al., 1998; Karsten et al., 2011) . In addition, it can use methionine, leucine, and α-aminoadipate as donors, with their corresponding 2-oxoacids as acceptors. Because ScAro8p possesses activity towards α-aminoadipate/2-oxoadipate, and S. cerevisiae mutant aro8 strains failed to grow in the presence of a mixture of tyrosine, tryptophan and phenylalanine, it was speculated to have an additional role as one of the glutamate/ 2-oxoadipate transaminases . Further evidence supporting the reclassification of ScAro8p as an α-aminoadipate aminotransferase derives from a recent study in which this enzyme was shown to display a greater specificity towards 2-oxoadipate compared to the aromatic amino acid substrates, such as phenylalanine and tyrosine (Karsten et al., 2011) . In this paper, we present results of our studies on cloning of two genes ARO8 (ORFs 19.2098 and 19.9645) , and YER152C, also known as C6_00210W (ORFs 19.1180 and 19.8771) , and characterization of the two Aro8p and Yer152Cp proteins from human pathogenic yeast Candida albicans, including their physicochemical properties, substrate specificity, inhibition studies and evidence indicating a different physiological role of both enzymes.
MATERIALS AND METHODS
Strains and growth conditions. E. coli TOP 10F' strain from Invitrogen was used in all cloning procedures. E. coli Rosetta (DE3) pLysS strain from Novagen was used for the overproduction of wild type CaAro8p, CaYer152Cp and C-oligoHis-tagged proteins (CaAro8CHp, CaYerCHp) . E. coli strains were cultured at 37°C on LB (Luria-Bertani) solid medium [1.0% (w/v) NaCl, 1.0% (w/v) tryptone, 0.5% yeast extract and 1.5% (w/v) agar] and LB liquid medium supplemented with 100 μg ml -1 ampicillin and/or 34 μg ml -1 chloramphenicol, when required.
Plasmids, enzymes and other materials. The plasmid used was pET101/D-TOPO (Invitrogen). Restriction enzymes were purchased from Fermentas and New England Biolabs. Protein mass markers were from Thermo Scientific. DNA polymerase was purchased from DNA-Gdansk. Purification of C-oligoHistagged proteins was performed on a HisTrapFF column (GE Healthcare). Purification of native proteins was performed on a ResourceQ column (GE Healthcare). Molecular mass determination was carried out with the Novex NativeP-AGE Bis-Tris gel system (Life Technologies) and with gel filtration using Superdex 200 HR 10/30 GL (GE Healthcare Life Sciences). Monoclonal peroxidase conjugated anti-polyHistidine antibody [HIS-1] and 3, 3', 5, 5'-tetramethylbenzidine, substrates and their analogues, as well as lysine derivatives, were from Sigma. Reagents for determining the activity and inhibition studies were also purchased from Sigma.
DNA manipulations. Candida albicans SC5314 genomic DNA was isolated according to the protocol of Bacterial & Yeast Genomic DNA Purification Kit (DNA-Gdansk). Isolation of plasmid DNA was carried out according to the protocol of the Plasmid Mini kit (A&A Biotechnology). DNA fragments were isolated from agarose gels following the standard procedure of the GenElute Gel Extraction Kit (Sigma-Aldrich). DNA digestion with restriction enzymes was carried out according to the enzyme supplier's instructions.
Cloning of the ARO8 and YER152C gene. The fragment of the ARO8 gene encoding aromatic/aminoadipate aminotransferase was amplified from the C. albicans SC5314 genomic DNA by PCR. The primers used in the amplification were: ARO8.f 5'CAC-CATGACTAGTGATACAAAGCCACAGGCT3'and ARO8CH.r 5'AAACTCGAGCTAATGGTGATGGT-GATGATGATGCAATCCAAACTCGGCTCTGA-CAG3' for CaAro8CHp oligoHis-tagged fusion protein and ARO8.f and ARO8.r 5'AAACTCGAGCTA-CAATCCAAACTCGGCTCTGACAG 3' for the wild type ARO8 gene cloning. The fragment of YER152C gene was amplified with the use of the following primers: YER.f 5'CACCATGATAAACTTCTTCAAGG-GCCACC3' and YERCH.r 5'CTAATGATGATGAT-GATGATGATGTTCTAAAAGTTCTCCCCAAATC3' for CaYerCHp oligoHis-tagged fusion protein and YER.f and YER.r 5'TAACTATTCTAAAAGTTCTC-CCCAAATCTTG3' for the wild type YER152C gene cloning. The hexaHis-tag-encoding sequence introduced in the reversed primers are in bold. Primers were designed according to Invitrogen's instructions. The PCR products (1476 bp and 1494 bp for ARO8, 1248 bp and 1266 bp for YER152C, wild type or with oligo-His constructs, respectively) were purified from an agarose gel and cloned directionally into the pET101/D-TOPO vector giving recombinant expression plasmids: pET101/D-TOPO+ARO8CH (7274 bp), pET101/D-TOPO+ARO8 (7256 bp) and pET101/D-TOPO+YERCH (7046 bp), pET101/D-TOPO+YER152C (7028 bp). The identity of the plasmids was confirmed by restriction analysis and DNA sequencing. The obtained constructs encoded the putative CaAro8p and CaYer152Cp, as well as the same proteins with an additional oligoHis-tag at the C-terminus (CaAro8CHp and CaYerCHp).
Overexpression of the ARO8 and YER152C genes. E. coli Rosetta (DE3) pLysS cells, transformed with the pET101/D-TOPO+ARO8CH, pET101/D-TOPO+ARO8, and pET101/D-TOPO+YERCH, pET101/D-TOPO+YER152C expression plasmids, were grown in LB liquid medium with ampicillin and chloramphenicol, overnight at 37°C. Samples of the cultures (10 ml) were then transferred to a fresh LB broth (1 L) containing both antibiotics and grown at 37°C. Expression was induced by the addition of 0.05 mM isopropyl-β-D-thiogalactopyranoside to the cultures grown to OD 600 0.4-0.6, and incubation was continued at 30-37°C for another 5-15 h. Cells were harvested by centrifugation at 4000×g for 20 min, at 4°C, and stored for further use at -20°C.
Purification of the oligoHis-tagged Aro8p and Yer152Cp. The C-oligoHis-tagged CaAro8CHp and CaYerCHp were purified by metal-affinity chromatography. Bacterial pellet was resuspended in buffer A (20 mM Tris-HCl, pH 8, 5 mM imidazole, 0.6 M NaCl and 0.5 mM phenylmethylsulfonyl fluoride /PMSF/) and the cells were disrupted by sonication (5 × 30 s bursts, with 30 s intervals, at a power setting of 30, using a Branson sonifier 250) on ice. The total lysate was centrifuged at 16 000 × g for 20 min, at 4°C. The supernatant (crude extract) was applied to a HisTrapFF column, bed volume 5 ml, which was pre-equilibrated with 5 column volumes (CV) of buffer A. Next, the column was washed with 5 CV of the same buffer. The oligoHis-tagged proteins were eluted by increasing concentrations of imidazole in elution buffer B (20 mM Tris-HCl, pH 8, 500 mM imidazole, 0.5 M NaCl, gradient of buffer A and B: 0-100%). For further assays, the eluates were concentrated by ultrafiltration using Vivaspin concentrators (10 kDa cut-off limit; Viva Science Ltd.) at 7 000 × g for 30 min, at 4°C, if necessary. The protein preparations were frozen at -20°C in 50 mM phosphate buffer, pH 7.5, with PLP in slight molar excess over the enzyme, and stored for further use.
Purification of the wild type Aro8p and Yer152Cp from C. albicans. The supernatant (crude extract) in buffer C (20 mM phosphate buffer, pH 7, 1 mM DTT, 0.5 mM phenylmethylsulfonyl fluoride /PMSF/) obtained after sonication of E. coli Rosetta (DE3) pLysS cells, transformed with the pET101/D-TOPO+ARO8 and pET101/D-TOPO+YER152C expression plasmids, was treated with streptomycin sulfate (1.2%) to remove nucleic acids. The resulting mixture was centrifuged (15 500 × g, 20 min, 4°C). The obtained supernatant was collected for further use at 4°C. Ammonium sulfate was added to 30% saturation, which was found to be the optimal value in order to remove the accompanying proteins with no significant loss of the wild-type CaAro8p and CaYer152Cp activity. The suspension was incubated in the ice bath for 20 min and then centrifuged (15 500 × g for 20 min at 4°C). Supernatant was discarded and the precipitate was dissolved in 10 ml of buffer D (20 mM potassium phosphate buffer, pH 7) with addition of 10 mM MgCl 2 and 10 mM NaCl. Proteins were desalted using HiTrap Desalting Columns (GE Healthcare) according to the manufacturer's procedure. The desalted proteins were loaded onto ResourceQ FPLC 6-ml column (GE Healthcare) equilibrated with buffer D. The column was then washed with 20 ml of the same buffer. The wild-type protein was eluted by a gradient of buffer E (buffer D containing 1M NaCl, gradient of buffer D and E: 0-50%). Fractions exhibiting aminotransferase activity were pooled and concentrated by ultrafiltration. Samples were then held frozen (-20°C) in 50 mM phosphate buffer pH 7.5, with PLP in slight molar excess over enzyme and stored for further use.
Western-Blott analysis. Proteins were separated on 15% polyacrylamide gel according to Laemmli (Laemmli, 1970) . Electrophoresis was followed by electroblotting to a nitrocellulose membrane with the use of a transfer buffer (25 mM pH 8.3, 192 mM glycine, 20% methanol) . Nitrocellulose membranes were incubated in 3% skimmed milk solution, in washing buffer: 10 mM Tris-HCl, pH 8.0, 30 mM NaCl, for 1h. After three time washing with washing buffer, membranes were incubated for 1h with monoclonal peroxidase conjugated anti-polyHistidine antibody [HIS-1] 1:2000 solution. CaAro8CHp or CaYerCHp were detected by the addition of peroxidase substrate 3, 3', 5, 5'-tetramethylbenzidine (TMB) according to manufacturer's instructions (Sigma).
Molecular-mass determination of the native protein. Size-exclusion chromatography was performed on Superdex 200 HR 10/30, proteins were eluted at a flow rate of 0.5 ml min -1 with 25 mM potassium phosphate buffer (pH 7.0) containing 0.15 M NaCl. Protein elution was monitored at 280 nm. The molecular-mass standards were: α-amylase (200 kDa), alcohol dehydrogenase (150 kDa), bovine serum albumin (66 kDa), carbonic anhydrase (29 kDa), and cytochrom c (12.4 kDa). Oligomeric structure was also analyzed by native PAGE electrophoresis using the NativePAG Novex 4-16% Bis-Tris Gels kit (Invitrogen). The experiments were run according to the manufacturer's procedure. Kinetic measurements and substrate specificity studies. In all assays, 2.5 μg of purified enzyme was used.
Aromatic amino acid degradation. The concentration of amino group donor (l-Phe, l-Tyr, l-Trp) was 0.006-10 mM, and amino group acceptor was 0.25-20 mM (2-oxoglutarate, pyruvate, gloxylate, 2-oxoadipate). The reaction was carried out in 100 mM Tis-HCl pH 7.5 with 0.03 mM of PLP, in the final volume of 200 μl. The reaction mixtures containing all the required components except the enzyme, were preincubated for about 3 min and the reaction was started by an addition of the enzyme to the mixture and run for 2 min at room temperature (RT). This time period was chosen as optimal for determination of initial reaction rates. The reaction was then terminated by addition of 800 μl of 2.5 M NaOH. The product formation was measured spectrophotometrically with the use of Spectrophotometer UVVis PerkinElmer Lambda 45 6K15 (320 nm for phenylpyruvate (PhP); ε 17 700 dm 3 cm -1 mol -1 , 331 nm for 3-indolepyruvate; ε 19 900 dm 3 cm -1 mol -1 and 338 nm for 4-hydroxyphenylpyruvate (4-hydroxyPhP); ε 9 300 dm 3 cm -1 mol -1 ).
Aromatic amino acids biosynthesis. The concentration of amino group donor (L-Glu) was 1.5-45 mM and amino group acceptor was 0.005-0.06 mM (PhP, 4-hydroxyPhP). The reaction was carried out in 100 mM TisHCl pH 7.5 with 0.03 mM of PLP, in the final volume of 200 μl, and started by the addition of the enzyme as mentioned above. After 2 min of incubation, 800 μl of 2.5 M NaOH was added. The level of product formation, Phe or Tyr, was estimated by a spectrophotometrically measured decrease in the PhP and 4-hydroxyPhP absorbance, respectively (320 nm for PhP; ε 17 700 dm 3 cm -1 mol -1 and 338 nm for 4-hydroxyPhP; ε 9 300 dm 3 cm -1 mol -1 ).
α-Aminoadipate biosynthesis. The concentration of l-glutamate used was 2-20 mM, and 2-oxoadipate was at 0.2-1.5 mM. The reaction was carried out under the same conditions as mentioned above, and run for 5 min at RT. This time period was chosen as optimal for determination of initial reaction rates. The reaction was then terminated by addition of 60 μl of 1 M HCl. Then, 60 μl of 1 M NaOH was added for neutralization. 100 μl of the reaction mixture was added to 750 μl of 20 mM phosphate buffer pH 7 containing 0.05 M NH 4 Cl, 0.1 mM NADH and 2.5 U of L-glutamic dehydrogenase. Formation of NAD + was measured spectrophotometrically after 30 min of incubation in RT (340 nm; ε 6 200 dm 3 cm -1 mol -1 ).
α-Aminoadipate degradation. The concentration of α-aminoadipate used was 0.01-0.2 mM, and 2-oxoglutarate was at 0.1-5 mM. The reaction was carried out under the same conditions as mentioned above, and run for 2 min at RT. The reaction was then terminated by incubation at 80°C for 5 min. After cooling on ice, 20 μl of the reaction mixture was used for determining the amount of the reaction product. The formation of glutamate was measured spectrophotometrically with the use of l-Glutamate Assay Kit (Sigma) according to the manufacturer's instructions.
Aro8CHp inhibition studies. The effect of different compounds on Aro8CHp activity was determined by measuring the enzyme activity in standard assay mixtures containing various concentrations of 2-OG analogues: oxalate, glyoxylate, oxobutyrate, and amino donor group analogues like: l-canavanine, l-norleucine, l-lysine, diaminopimelate, pipecolate.
Determination of optimal pH. Determination of optimal pH for the enzyme was done by measuring activity as described above with changing pH of the assay buffer, ranging from 6 to 9.
Other methods. Protein concentration was determined by the Bradford method (Bradford 1976) . Discontinuous SDS/PAGE was performed by the method of Laemmli (Laemmli, 1970 ) using a 12% (w/v) separating gel and a 5% (w/v) stacking gel.
RESULTS AND DISCUSSION
It has been known that in S. cerevisiae open reading frames, YGL202W (ARO8) and YER152C encode enzymes that harbor α-aminoadipate aminotransferase activity (King et al., 2009 (Fig. 2) and amino acid sequence analysis revealed the presence of conserved residues.
Cloning and expression of the CaARO8 and CaYER152C genes
The CaARO8 and CaYER152C genes were cloned into the expression vector pET101/D-TOPO in a system that enabled overproduction of recombinant wild type proteins or proteins containing the C-terminal oligoHis-tag sequence. The PCR fragments amplified by using the indicated primers (ARO8.r, ARO8CH.r and ARO8.f for ARO8, and YER.r, YERCH.r and YER.f for YER152C) were cloned into the pET101/D-TO-PO expression plasmid according to Invitrogen's procedure. Resulting pET101/D-TOPO+ARO8, pET101/D-TOPO+ARO8CH and pET101/D-TOPO+YER152C, pET101/D-TOPO+YERCH plasmids were sequenced. The expression plasmids, in which the ARO8 or YER152C genes are placed under the control of a T7 promoter, were transferred into E. coli Rosetta (DE3) pLysS strain. Overexpression of the cloned genes, induced upon IPTG addition resulted in a production of soluble wild type and oligoHis-tagged proteins in E. coli cells.
Purification of CaAro8p and CaYer152Cp
The purification of recombinant CaAro8p or CaYer152Cp was achieved in several steps including streptomycin sulfate, ammonium sulfate precipitation and ion exchange chromatography. Fractions eluted from the ResourceQ column by NaCl gradient were analyzed by SDS-PAGE (Fig. 3) . Densitometric analysis shows ≥ 91% homogeneity of CaAro8p fraction, and ≥ 61% homogeneity of CaYer152Cp fraction (GelQuant Pro).
Purification of CaAro8CHp and CaYerCHp
The purification of recombinant CaAro8CHp or CaYerCHp was achieved in a single chromatographic step with the use of HisTrapFF column. Fractions eluted from the column by an imidazole gradient were analyzed by SDS-PAGE (Fig. 4A ) and Western blotting (Fig. 4B) . The recombinant proteins were purified to near homogeneity (≥ 98% for CaAro8CHp) or with purity sufficient for kinetic analysis (≥ 74% for CaYerCHp), as revealed by densitometry (GelQuant Pro). Western blotting analysis confirmed presence of the oligoHis-tagged fusion proteins in the appropriate fractions.
Characterization of CaAro8p and CaYER152Cp molecular and catalytic properties

Molecular mass
Results of the SDS-PAGE analysis indicated MW of the CaAro8CHp subunit equal to 55 ± 9062 kDa and that of the CaYerCHp to 48 ± 2kDa, in agreement with the theoretical values of 56.4 kDa and 47.3 kDa, respectively. Molecular subunit composition and MWs of native forms of both recombinant proteins were estimated using the size exclusion chromatography (SEC) and blue native gel analysis. Peak present in the CaAro8CHp SEC profiles eluted at volume corresponding to MW 73.5 ± 8 kDa. Results obtained by electrophoresis under non-denaturing conditions revealed the presence of two protein bands corresponding to the molecular masses of 69.5 ± 10.5 kDa and 141.5 ± 40 kDa. Results of both analyses revealed that CaAro8p may exist as a monomer, although the results obtained by blue native gel analysis seem to indicate the presence of dimeric forms. Crystal structures of enzymes exhibiting mainly aromatic aminotransferase activity from S. cerevisiae (ScAro8p), putative α-aminoadipate aminotransferase (Bulfer et al., 2013) and α-aminoadipate aminotransferase from Thermus thermophilus (ThtLysN) ) revealed that both exist as homodimers. Human kynurenine aminotransferase II (hKATII) that notably catalyzes the synthesis of kynurenic acid (KYNA) but is unique in having α-aminoadipate aminotransferase activity is also supposed to be a homodimer (Han et al., 2009) .
The same results were obtained for CaYerCHp. Peak present in the SEC profiles eluted at a volume corresponding to MW 63 ± 6 kDa. Results obtained by electrophoresis under non-denaturing conditions revealed the presence of two protein bands, corresponding to the molecular masses of 55 ± 8 kDa and 97 ± 27 kDa. Results of both analyses suggested a monomeric or dimeric structure of CaYerCHp, although it is unusual for aminotransferases to form monomers. For example, alanine aminotransferases from P. furious and C. maltosa are dimers (Ward et al., 2000; Umemura et al., 1994) . The same oligomeric structures are observed for both, asparte aminotransferases from B. subtilis or E. coli (Sung et al., 1990; Smith et al., 1989) , as well as for aromatic aminotransferases from S. cerevisiae (Bulfer et al., 2013) . As far as we know, our results concerning oligomeric structure of CaYerCHp are reported for the first time for Yer152Cp from any organism. Highly conserved residues are marked as white letters on a red background, similarities are marked in red, the most important residues participating in substrate and PLP binding in hKATII and ScAro8p are marked in bold black frame (Rossi et al., 2008; Han et al., 2009; Bulfer et al., 2013) . ClustalW (Larkin et al., 2007) was used to perform a multiple sequence alignment and ESPript (Robert & Gouet 2014) was used to produce the figure. A K. Rząd and I. Gabriel 
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Kinetic properties and substrate specificity
To characterize both ARO8 and YER152C gene products in detail, kinetic analysis was carried out with purified oligoHis-tagged proteins and compared to their wild type counterparts. To understand the role of CaAro8p and CaYer152Cp, a screen of several potential substrates for the aromatic and/or aminoadipate aminotransferase was undertaken. CaAro8p showed transamination of PhP and 4-hydroxyPhP as the amino acceptors, and lGlu as the amino donor to produce phenylalanine and tyrosine, respectively. Similar analysis was done in the reverse reaction, at the same pH, with l-Phe or l-Tyr and 2-oxoglutarate as the amino donor and the amino acceptor, respectively, to determine K m values (Table 1) . From this analysis, we concluded that CaAro8p is mainly a biosynthetic enzyme devoted to aromatic amino acid biosynthesis. The enzyme was shown to display greater affinity towards PhP and 4-hydroxyPhP than Phe or Tyr.
Our results are similar to those obtained for a corresponding enzyme from S. cerevisiae, which was initially identified as an aromatic aminotransferase I (ScAro8p), an enzyme involved in the biosynthesis of phenylalanine and tyrosine (Kradolfer et al., 1982) . Those authors postulated that ScAro8p plays an essentially biosynthetic role, being the only aromatic aminotransferase present in cells grown on minimal medium containing ammonium ions as a sole nitrogen source.
We next analyzed the transamination reaction with several 2-oxoacids as the amino acceptors by using phenylalanine as an amino donor (Table 2) .
Our results indicate a broad spectrum specificity of CaAro8p. Furthermore, CaAro8p was able to utilize l-Glu as an amino group donor and 2-oxoadipate as an amino group acceptor to produce α-aminoadipate. Our results indicate that aromatic aminotransferase I (CaAro8p) from C. albicans plays an important role in L-lysine biosynthesis as an α-aminoadipate aminotransferase. In addition, K m value determined for l-Glu and 2-oxoadipate was one order of magnitude greater than that obtained for l-Glu and phenylpuryvate, or l-Glu and 4-hydroxyphenylpuryvate (Table 1) .
The ability of the ARO8 encoded aminotransferase to utilize both, aromatic and dicarboxylic acid substrates, appears to be a common feature of this class of aminotransferase enzymes. The aromatic aminotransferase from Paracoccus dentrificans (PdAro8p) is an example. This aminotransferase can use both, acidic and aromatic amino acids as substrates (Okamoto et al., 1998) . PdAro8p has the ability to switch its recognition site from a carboxylate side chain to an aromatic side chain by rearranging a set of active site residues to accommodate the aromatic amino acid. The human α-aminoadipate/l-kynurenine aminotransferase II (hKAT II) has been reported to use 16 amino acids as substrates, with a wide range of side chains and a similarly wide range of 2-oxoacids as amino group acceptors (Han et al., 2009) . The crystal structure of the human enzyme hKATII in complex with l-kynurenine reveals amino acid residues in the active site that are in contact with l-kynurenine ( Fig. 2A) . Five of these residues are conserved in the enzyme from S. cerevisiae (Gly43', Tyr105', Asn220, Arg470, Lys305) and the remaining three are conservatively substituted (Tyr142, Val199 and Arg20 in hKATII for Phe166, Ile215 and Lys26 in ScAro8p, respectively). The pocket that accommodates the aromatic side chain of l-kynurenine in the 
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human enzyme could potentially accommodate the aliphatic portion of a substrate, such as l-α-aminoadipate. Karsten et al. suggests that similar interactions could be involved in the yeast enzyme (Karsten et al., 2011) . Data obtained from a crystal structure of ScAro8p (Bulfer et al., 2013) indicate that four of these residues, Gly43', Asn220, Arg470 and Tyr105' are mainly involved in different substrate binding. Those residues are also highly conserved in ThtLysN, hKATII and Bos taurus, and are involved in the catalysis (Han et al., 2009; Tomita et al., 2009; Ouchi et al., 2009) . The corresponding residues are also present in the CaAro8p and CaYer152Cp amino acid sequences (Gly46', Asn218, Arg463 and Tyr105' from CaAro8p, and Gly7', Asn189, Arg392 and Tyr47' from CaYer152Cp). Multiple sequence alignment analysis also shows other conserved residues among species ( Fig. 2A) . The eight most important residues participating in substrate and PLP binding to hKATII are identical or conservatively substituted in CaAro8p. There are only 3 differences between these residues comparing to eight most important residues from hKATII and there is no difference comparing to ScAro8p. There is a change in hKATII Arg20 to Lys29 in CaAro8p (similarly in ScAro8p there is Lys26). This substitution may be significant for the enzyme affinity against substrates. It has been reported that modification of Arg23 residue in LysN from T. thermophilus (corresponding to Arg20 residue in hKATII) decreases the catalytic efficiency for glutamate as a substrate (Ouchi et al., 2009) . N-phosphopyridoxyl-α-aminoadipate (PPA) and kynurenine substrates in ThtLysN and hKATII, respectively, are also recognized by a conserved arginine residue (Arg23 in ThtLysN and Arg20 in hKATII). In ThtLysN, the δ-carboxylate group of the aminoadipate moiety of PPA is stabilized through salt bridge interactions with the guanidinium group of Arg23 in ThtLysN , and the corresponding residue in hKATII, Arg20, participates in cation-π stacking with the kynurenine substrate (Rossi et al., 2008; Han et al., 2009) . As was mentioned above, in ScAro8p, this arginine is substituted with Lys26, and this lysine residue may rearrange to play an important role in substrate recognition, analogous to the corresponding arginine residue in ThtLysN and hKATII. A model of kynurenine bound to the active site of ScAro8p displays similarities to the kynurenine-bound structure of hKATII indicating that enzyme from S. cerevisiae may be able to process this substrate despite the presence of Lys26. Our preliminary studies confirmed that despite the occurrence of an analogous lysine residue, Lys29 in C. albicans Aro8p sequence, CaAro8p is able to catalyze kynurenine transamination (data not shown). Another difference is observed for the Tyr142 residue from hKATII. In CaAro8p, the Tyr residue is replaced by Phe166. Similar change is observed for several AmAA, like ScAro8p, hKATI and AmAA from Mus musculus. It is known that Tyr142 from hKATII participated in PLP binding, nevertheless more often Phe or Trp fulfills that function (Rossi et al., 2008) . PLP forms a Schiff base with the α-amino group of Lys305 from ScAro8p (Bulfer et al., 2013) . This residue is highly conserved among species and is also present in the CaAro8p and CaYer152Cp amino acid sequences (Lys300 and Lys256, respectively). Based on this observation and amino acid sequence alignment, substrates of CaAro8p and CaYer152Cp are predicted to bind through similar interactions with these residues.
According to a previous report suggesting that Yer152Cp from S. cerevisiae has an aminoadipate aminotransferase activity (King et al., 2009 ), a corresponding gene (Table 3) . The specific activity is one order of magnitude lower for each aromatic amino acid. When similar analysis was done in the reverse reaction, at the same pH, with PhP and 4-hydroxyPhP as the amino acceptors, and L-Glu as the amino donor, to produce phenylalanine and tyrosine, respectively, no activity was detected.
Our results indicate that CaYer152Cp has a possible role in aromatic amino acid degradation. This narrow substrate spectrum is surprising due to the sequences similarity of the most important residues. Multiple sequence alignment shows that CaYer152Cp has six identical residues in the active site, as does hKATII (Fig. 2B) . There are only two differences in the eight most important residues participating in substrate and PLP binding to hKATII. Val199 from hKATII is substituted by Ile184 (similar to ScARO8p Ile215), Tyr142 is replaced by Leu124. Despite such small differences, Tyr142 substitution for Leu124 seems to be crucial for the enzyme's activity and substrate recognition. It has been reported that Tyr142 together with Asn202, Gly39' and Tyr74' define the hKATII binding-site (Han et al., 2009 ). Tyr142 in hKATII substituted for Phe125 in hKATI determined differences in substrate recognition (Rossi et al., 2008) . All aminotransferases being compared (Fig. 2) , show a wide substrate spectrum and have corresponding aromatic residues (Phe or Tyr). Although only in the case of CaYer152Cp's amino acid sequence there is a lack of equivalent Tyr or Phe residue, the assumption of Leu124 having a crucial role needs further analysis.
N-phosphopyridoxyl-α-aminoadipate (PPA) and kynurenine substrates in ThtLysN and hKAT II, respectively, are also recognized by a conserved arginine residue (Arg23 in ThtLysN, and Arg20 in hKAT II) . In CaYer152Cp there is an Arg11 (Fig. 2B ) that may correspond to the Arg23 in ThtLysN, and Arg20 in hKATII. Preliminary results of CaYer152Cp activity with kynureine as a substrate, confirmed that the enzyme from C. albicans is able to catalyze kynurenine transamination (data not shown).
The effect of pH on enzyme activity
To analyze whether there are some differences concerning the optimal pH for the reactions catalyzed by CaAro8CHp and CaYer152Cp, we analyzed the effect of pH on the enzyme activity (Fig. 5) . The estimated optimal pH for both, CaAro8CHp and CaYer152Cp, was pH 8. The same results were obtained regardless of the reaction analyzed, neither aromatic amino acids degradation nor biosynthesis was differentially affected by pH. Similar optimal pH was observed for ScAro8p (pH 8.5) (Matsuda & Ogur, 1969) .
CaAro8CHp inhibition studies
Due to the potential role of the enzyme with α-aminoadipate aminotransferase activity as an antifungal drug target, inhibition analyses were carried out. In our present studies, we analyzed the influence of several 2-OG and 2-oxoacid analogues on Aro8CHp activity. Compounds were selected according to the lack of C2-oxo group and the length of chain (dicarboxylic acids, such as glutarate, succinic acid and oxalate) or the lack of carboxyl group corresponding to the following groups at the C5 position of 2-oxoglutarate (2-oxoacids like glyoxylic and 2-oxobutyric acid). According to the previous reports concerning inhibition of murine kynurenine aminotransferases by some proteinogenic amino acids (Han et al., 2010) , the effect of selected amino acids on Aro8CHp activity was also analyzed. Aro8CHp was not inhibited by the end product of the α-aminoadipate pathway, l-lysine and its derivative, l-canavanine. On the other hand, moderate inhibition of Aro8CHp was observed for l-norleucine and oxalic acid, with IC 50 2.8 ± 1.31 mM and 6.3 ± 1.01 mM, respectively. There was neither inhibitory effect for diaminopimelic acid, a precursor in l-lysine biosynthesis in bacteria, nor for pipecolic acid-amino acid analogue. The same situation was observed for oxobutyric acid and glyoxylic acid. Both were recognized by CaAro8p as substrates.
In conclusion, two ARO8 and YER152C genes of Candida albicans were unequivocally identified as encoding aminotransferases. The genes were cloned, sequenced, and overexpressed in Escherichia coli, as wild type and fusion proteins with C-terminal oligoHis-tag. In this respect, it is worth mentioning that as far as we know, our results concerning the physicochemical properties, substrate specificity, inhibition studies and evidence provided for physiological role of CaYer152Cp, comprise the first report ever for Yer152Cp from any organism. CaAro8p is the first aromatic/aminoadipate aminotransferase from human pathogenic fungi that was isolated and characterized. This enzyme's essential role in aromatic amino acid and lysine biosynthesis was identified. Moreover, CaAro8p exhibited the ability to catalyze the reverse reaction, the aromatic amino acid degradation. On the other hand, despite high degree of similarity in amino acid sequence, CaYer152Cp is able to catalyze only the conversion of l-Phe or l-Tyr and 2-oxoglutarate, as the amino donors and the amino acceptor, respectively. Our results indicate that CaYer152Cp has a possible role in aromatic amino acid degradation. 
